NCCN Guidelines® Insights: Prostate Cancer, Version 3.2024.
Publication
, Journal Article
Schaeffer, EM; Srinivas, S; Adra, N; An, Y; Bitting, R; Chapin, B; Cheng, HH; D'Amico, AV; Desai, N; Dorff, T; Eastham, JA; Farrington, TA ...
Published in: J Natl Compr Canc Netw
April 2024
The NCCN Guidelines for Prostate Cancer include recommendations for staging and risk assessment after a prostate cancer diagnosis and for the care of patients with localized, regional, recurrent, and metastatic disease. These NCCN Guidelines Insights summarize the panel's discussions for the 2024 update to the guidelines with regard to initial risk stratification, initial management of very-low-risk disease, and the treatment of nonmetastatic recurrence.
Duke Scholars
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
April 2024
Volume
22
Issue
3
Start / End Page
140 / 150
Location
United States
Related Subject Headings
- Risk Assessment
- Prostatic Neoplasms
- Oncology & Carcinogenesis
- Neoplasms, Second Primary
- Male
- Humans
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Schaeffer, E. M., Srinivas, S., Adra, N., An, Y., Bitting, R., Chapin, B., … Freedman-Cass, D. A. (2024). NCCN Guidelines® Insights: Prostate Cancer, Version 3.2024. J Natl Compr Canc Netw, 22(3), 140–150. https://doi.org/10.6004/jnccn.2024.0019
Schaeffer, Edward M., Sandy Srinivas, Nabil Adra, Yi An, Rhonda Bitting, Brian Chapin, Heather H. Cheng, et al. “NCCN Guidelines® Insights: Prostate Cancer, Version 3.2024.” J Natl Compr Canc Netw 22, no. 3 (April 2024): 140–50. https://doi.org/10.6004/jnccn.2024.0019.
Schaeffer EM, Srinivas S, Adra N, An Y, Bitting R, Chapin B, et al. NCCN Guidelines® Insights: Prostate Cancer, Version 3.2024. J Natl Compr Canc Netw. 2024 Apr;22(3):140–50.
Schaeffer, Edward M., et al. “NCCN Guidelines® Insights: Prostate Cancer, Version 3.2024.” J Natl Compr Canc Netw, vol. 22, no. 3, Apr. 2024, pp. 140–50. Pubmed, doi:10.6004/jnccn.2024.0019.
Schaeffer EM, Srinivas S, Adra N, An Y, Bitting R, Chapin B, Cheng HH, D’Amico AV, Desai N, Dorff T, Eastham JA, Farrington TA, Gao X, Gupta S, Guzzo T, Ippolito JE, Karnes RJ, Kuettel MR, Lang JM, Lotan T, McKay RR, Morgan T, Pow-Sang JM, Reiter R, Roach M, Robin T, Rosenfeld S, Shabsigh A, Spratt D, Szmulewitz R, Teply BA, Tward J, Valicenti R, Wong JK, Snedeker J, Freedman-Cass DA. NCCN Guidelines® Insights: Prostate Cancer, Version 3.2024. J Natl Compr Canc Netw. 2024 Apr;22(3):140–150.
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
April 2024
Volume
22
Issue
3
Start / End Page
140 / 150
Location
United States
Related Subject Headings
- Risk Assessment
- Prostatic Neoplasms
- Oncology & Carcinogenesis
- Neoplasms, Second Primary
- Male
- Humans
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis